U.S. Tariffs: The Geopolitical Shock Reshaping Global Pharma
Trump’s Tariffs and the Future of Pharma: A Geopolitical Turning Point for the Global Industry As Donald Trump returned to the White House in January 2025, few expected his administration to disrupt the global pharmaceutical industry so swiftly and profoundly. Within months, a series of bold announcements—centered on steep import tariffs and aggressive drug pricing […]
What Will Shape Pharma in 2026? Key Innovations and Strategic Moves
The pharmaceutical industry continues to evolve under the pressure of medication affordability, regulatory constraints, and growing environmental expectations. In 2025, drug manufacturers face a major challenge: ensuring laboratories profitability while accelerating innovation and industrial performances. Lactalis Ingredients Pharma, as a committed lactose pharmaceutical manufacturer, closely follows these transformations to better support its partners and customers’ […]
Drug Production in France: 3.5 Billion Medicines and a Resilient Healthcare Ecosystem
Drug production: understanding the French healthcare ecosystem Since the early 2000s, the French pharmaceutical industry has undergone significant changes, marked in particular by a sharp decline in domestic drug production and a reduction in its industrial capacity, which halved between 2005 and 2023 (46.5B$ of revenue in 2023).¹ Despite France’s massive investment in research and development, these efforts have not been […]
Which Policies to Support Pharmaceutical Innovation?
At a time of challenges that call for change, it is necessary to place health at the heart of public policy.[1] The importance of pharmaceutical innovation cannot be underestimated, in the interests of public health and the economy alike. By responding to medical needs that are poorly covered or not at all,[2] it offers therapeutic […]
European Pharmaceutical Sovereignty: The Role of Local Excipients
Discover how local excipients like pharmaceutical-grade lactose from Lactalis Ingredients Pharma strengthen European pharmaceutical sovereignty by ensuring reliable, high-quality supply chains. Ensuring European Pharmaceutical Sovereignty: The Key Role of Local Excipients The growing need for pharmaceutical sovereignty has become a critical concern for Europe. Recent supply chain disruptions have exposed vulnerabilities in the availability of […]
Navigating the Pharmaceutical Landscape: Exciting Challenges and Innovations for 2025
Each year, the pharmaceutical industry faces new challenges, and 2024 was no exception. From navigating complex regulatory landscapes to integrating cutting-edge technologies, the industry has had to adapt and innovate continuously. In 2024, we witnessed significant advancements in personalized medicine, the rise of telehealth, and the ongoing battle against global health crises. These developments have […]
Pharmaceutical challenges : what to expect in 2024 ?
Each year, new pharmaceutical challenges are faced by the industry. 2023 saw the more widespread use of artificial intelligence (AI), the Nobel Prize in Physiology or Medicine awarded for research into mRNA vaccines, as well as advances in the treatment of malaria and in oncology. In 2024, these challenges are set to continue, but at […]
How can we respond to the loss of French and European health sovereignty?
Health sovereignty refers to a country’s ability to take charge of the pharmaceutical production chain and ensure the health of its population. The more a country relies on others for its supply of active ingredients, excipients, and production, the less sovereign it becomes. Today, France and Europe are facing the challenges of declining health sovereignty. […]